rais price
updat sales/ep estimate cc sell
day adj
cc sd adj chang
sale estimate incl higher hip knee estimate favor fx gm/om/tax
remain mostli unchang forecast compar
consensu sales/ep zbh sales/
ep guidanc cc organ
sd rais pt
estim glanc forecast sales/ep
cc cc organ sell day adj
compar consensu respect
guidanc rang cc
organ sd adj us/ou knee
forecast cc day adjust sale growth us
number exclud assum storm recoveri uplift weve
classifi differ sell day compar
basi us ou hip forecast cc day
adjust growth compar
basi ww hip estim cc cc/sd/weather
adj report compar consensu report
ww knee estim cc cc/sd/weather adj
report vs consensu report
item watch earn progress toward remedi
qualiti suppli issu price volum share trend global
hip knee market inclus prospect regain lost share new
product persona partial revis knee cement-less knee
major joint robot revenue/eps/margin guidanc inclus
slightli posit tax reform impact enhanc spend incentiv
salesforc growth prospect key set franchis abil regain
momentum spine disposit dental
rais sale exhibit updat sales/
ep estim cc report
cc report chang sale estim includ
favor fx higher hip knee forecast
margin assumpt gm/om decreas due
on-going remedi effort increas spend re-energ salesforc
continu pg
tr target
rais pt valuat risk use rel valuat framework
compound-annual-growth-rate get us rel forward price-to-earnings convolv month forward multipl
anticip cash earn arriv revis price target
frame refer trade forward multipl last day
posit thesi stock predic new sale product focus leadership abl
take fuller advantag zbh commerci footprint strong brand orthoped period
anticip overal top-lin compound-annual-growth-rate dont believ huge stretch rel
market play especi given recent mis-execut like revers
ww hip knee period model compound-annual-growth-rate respect set
enjoy faster grow sub-market extrem sport medicin model
spine model presumpt improv commerci execut benefit
spinal robot ldr disc gener modicum share momentum model compound-annual-growth-rate
dental space full portfolio admit uncertain whether new ceo
elect retain busi period anticip oper margin
remain flat structur basi saddl difficult defend hip
knee share post biomet acquisit view seem desir compani lessen
depend low singl digit major joint market aggress leverag proven
commerci organ non-major joint product risk includ execut misstep
under-perform vs end market manag change-rel uncertainti
page
exhibit revenu varianc segment product categori strh vs consensu
page
exhibit revenu varianc segment product categori strh vs consensu
page
page
million except per share interest expens inc analysisgross cmf sale sale cc org sd day sale inc inc
zimmer lead player musculoskelet devic segment player hip
ww share knee meaning presenc musculoskelet categori dental
cmf/thorac surgic sport medicin extrem trauma
spine ex-ldrh spun parent august headquart
posit thesi stock predic new sale product focus leadership
abl take fuller advantag zbh commerci footprint strong brand orthoped
period anticip overal top-lin compound-annual-growth-rate dont believ huge
stretch rel market play especi given recent mis-execut like
revers ww hip knee period model compound-annual-growth-rate respect
set enjoy faster grow sub-market extrem sport medicin model
spine model presumpt improv commerci execut benefit
spinal robot ldr disc gener modicum share momentum model
compound-annual-growth-rate dental space full portfolio admit uncertain whether
new ceo elect retain busi period anticip oper
margin remain flat structur basi saddl difficult defend
hip knee share post biomet acquisit view seem desir compani
lessen depend low singl digit major joint market aggress leverag proven
commerci organ non-major joint product
valuat risk
use rel valuat framework regress forward sale compound-annual-growth-rate vs rel forward
peer price-to-earnings zbh sale compound-annual-growth-rate get us rel forward price-to-earnings convolv
 forward multipl anticip cash earn
arriv price target frame refer trade forward
multipl last day risk rate price target includ execut misstep
under-perform vs end market manag change-rel uncertainti
compani mention note
bruce nudel herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
